CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

KALAKALA BIO, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $0.43 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$8.30M
RECENT INSIDER TRADES
  • 2025-10-24 · Reumuth Mary (CHIEF FINANCIAL OFFICER) · SELL
  • 2025-10-24 · Iwicki Mark T (Director) · SELL
  • 2025-10-24 · Brazzell Romulus K (SEE REMARKS) · SELL
  • 2025-10-24 · Bazemore Todd (Director) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders18
Shares held725,029
Value$1.26M
Percent of shares outstanding3.75%
As of quarter end2026-06-30
RECENT NEWS
  • KALA Bio Signs Non-Binding LOI to acquire Nationwide Telehealth Platform for $48M
  • Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products
  • KALA Bio adds Yenvy Truong to advisory team
  • KALA BIO, Inc. · 8-K (1.01,9.01)
  • KALA BIO, Inc. · 8-K (5.08,8.01)
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
KALA BIO, Inc. (KALA) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit